ArticleInternational journal of surgery case reports2025
Metastatic Merkel cell carcinoma with an unknown primary tumor presenting as lymphadenopathy: A case report.
Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A rare presentation of Merkel cell carcinoma in a young immunocompetent woman.JAAD case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and importanceMerkel cell carcinoma is one of the rare neuroendocrine tumors of the skin. Neuroendocrine nodal MCCUP is a rare and poorly understood malignancy. In this article, we introduce a case of MCCUP with primary manifestation of lymphadenopathy. CASE PRESENTATION: A 62-year-old woman presented with lymphadenopathy in the inguinal region, and the diagnosis of metastatic Merkel cell carcinoma was made in the excisional biopsy. The primary source of the tumor was not found in the imaging workup and the patient underwent lymphadenectomy. CLINICAL DISCUSSION: MCCUP is a rare subtype of MCC, with specific diagnostic criteria. Most MCCs are symptom-free, requiring biopsy for confirmation. NE tumor marker analysis is crucial for distinguishing NE carcinoma, with CK20 and another NE marker sufficient for MCCUP diagnosis. LCA is not found in MCC tumors, and Ki-67 is used for prognosis. Treatment includes surgery, radiotherapy, and sometimes chemotherapy, although its efficacy is debated.
conclusionMCCUP is a rare disease affecting primarily elderly, several treatment regimens have been considered for the treatment of this rare tumor. One of the treatments with good results can be extensive surgery and patient follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.